Comparative early results of a robotics-assisted endoscope holder in single port thoracoscopic surgery in the era of COVID-19.
Surg Endosc. 2022 Jul;36(7):5501-5509. doi: 10.1007/s00464-022-09054-8. Epub 2022 Feb 7. Wu CF, Wu CY, Chao YK, Gonzalez-Rivas D, Hsieh MJ, Pan YB, Yang LY.
Malignancy Prediction Capacity and Possible Prediction Model of Circulating Tumor Cells for Suspicious Pulmonary Lesions.
J Pers Med. 2021 May 21;11(6):444. doi: 10.3390/jpm11060444. Wu CY, Fu JY, Wu CF, Hsieh MJ, Liu YH, Liu HP, Hsieh JC, Peng YT.
Circulating Tumor Cells as a Tool of Minimal Residual Disease Can Predict Lung Cancer Recurrence: A longitudinal, Prospective Trial.
Diagnostics (Basel). 2020 Mar 6;10(3):144. doi: 10.3390/diagnostics10030144. Wu CY, Lee CL, Wu CF, Fu JY, Yang CT, Wen CT, Liu YH, Liu HP, Hsieh JC.
Superior Vena Cava Port Catheter Tip Confirmation: Quantified Formula for Intravascular Catheter Length versus Anatomic Landmark Reference.
Ann Vasc Surg. 2019 Oct;60:193-202. doi: 10.1016/j.avsg.2019.02.030. Epub 2019 May 8. Wu CY, Fu JY, Wu CF, Hsieh MJ, Wen CT, Cheng CH, Liu YH, Ko PJ.
Recommended irrigation volume for an intravenous port: Ex vivo simulation study.
PLoS One. 2018 Aug 14;13(8):e0201785. doi: 10.1371/journal.pone.0201785. eCollection 2018. Wu CY, Cheng CH, Fu JY, Chu Y, Wu CF, Chiu CH, Ko PJ, Liu YH.
lnitial experiences with a new design for a preattached intravenous port device.
J Biomed Mater Res B Appl Biomater. 2018 Apr;106(3):1017-1027. doi: 10.1002/jbm.b.33911. Wu CY, Fu JY, Wu CF, Cheng CH, Liu YT, Ko PJ, Liu YH, Chu Y.
Single port VATS mediastinal tumor resection: Taiwan experience.
Ann Cardiothorac Surg. 2016 Mar;5(2):107-11. doi: 10.21037/acs.2016.03.10. Wu CY, Heish MJ, Wu CF.
Prognostic value of metastatic N1 lymph angiolymphatic invasion in patients with pathologic node ratio and stage IIA non-small cell lung cancer. Medicine 2014Oct;93(20):e102(O)(SCI) Wu CF?, Wu CY?, Fu JY, Wang CW, Liu YH, Hsieh MJ, Wu YC.
Analysis of chest X-ray plain film images of intravenous ports inserted via the superior vena cava. Surg Today. 2014Aug;44(8):1513-21 Fu JY, Wu CF, Ko PJ, Wu CY*, Kao TC, Yu SY, Liu YH, Hsieh HC.
Chronic Obstructive Pulmonary Disease in Stage I Non-small Cell Lung Cancer That Underwent Anatomic Resection: The Role of a Recurrence Promoter. COPD 2014Aug;11(4):407-13 Kuo CH?, Wu CY?, Lee KY?, Lin SM, Chung FT, Lo YL, Liu CY, Hsiung TC, Yang CT*, Wu YC*.
A single-center study of vascular access sites for intravenous ports. Surg Today 2014Apr;44(4):723-31(O) Wu CF, Ko PJ, Wu CY*, Liu YH, Kao TC, Yu SY, Li HJ, Hsieh HC.
Risk factors and possible mechanisms of intravenous port catheter migration. Eur J Vasc Endovasc Surg 2012Jul;44(1):82-7(O) Wu CY, Fu JY, Feng PH, Liu YH, Wu CF, Kao TC, Yu SY, Ko PJ*, Hsieh HC.
Node/aorta and node/liver SUV ratios from (18)F-FDG PET/CT may improve the detection of occult mediastinal lymph node metastases in patients with non-small cell lung carcinoma. Acad Radiol 2012Jun;19(6):685-92 (O) Kuo WH?, Wu YC?, Wu CY?, Ho KC, Chiu PH, Wang CW, Chang CJ, Yu CT, Yen TC, Lin C*.
Risk factors and possible mechanisms of superior vena cava intravenous port malfunction. Ann Surg 2012May;255(5):971-5(O) Wu CY?*, Hu HC?, Ko PJ, Fu JY, Wu CF, Liu YH, Li HJ, Kao TC, Kao KC, Yu SY, Chang CJ, Hsieh HC.